Pear Bio Overview
- Status
-
Private
- Employees
-
24

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$16M
- Investors
-
19
Pear Bio General Information
Description
Developer of proprietary biomedical technologies designed for the treatment of cancer through the measurement of drug resistance in patients. The company's technology uses a proprietary hydrogel that can grow tumors outside the human body and replicate drug resistance to eliminate the trial and error process involved in cancer treatment, enabling patients to receive the right and effective treatment.
Contact Information
Website
www.pearbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
- Camburgh House
- 27 New Dover Road, Kent
- Cantenbury CT1 3DN
- England, United Kingdom
+44 0000000000
Pear Bio Timeline
Pear Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Later Stage VC (Series A) | 14-Apr-2023 | $16M | 000.00 | Completed | Generating Revenue | |
9. Seed Round | 01-Jan-2022 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
8. Accelerator/Incubator | 19-Oct-2021 | 00000 | Completed | Generating Revenue | ||
7. Angel (individual) | 03-Mar-2020 | 00000 | Completed | Generating Revenue | ||
6. Accelerator/Incubator | 20-Aug-2019 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
5. Accelerator/Incubator | 15-Jan-2019 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
4. Accelerator/Incubator | 31-Mar-2017 | 000.00 | Completed | Generating Revenue | ||
3. Accelerator/Incubator | 10-Jun-2015 | 000.00 | 000.00 | Completed | Generating Revenue | |
2. Grant | 11-May-2015 | $10K | Completed | Generating Revenue | ||
1. Accelerator/Incubator | 01-Feb-2015 | Completed | Generating Revenue |
Pear Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-5 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Seed-4 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Seed-3 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Seed-2 | 1,775,956 | $0.000010 | 8% | $0.07 | $0.07 | 1x | $0.07 | 7.3% |
Seed-1 | 7,307,114 | $0.000010 | 8% | $0.46 | $0.46 | 1x | $0.46 | 28.59% |
Pear Bio Patents
Pear Bio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230008421-A1 | Method of forming solid cell cultures | Pending | 08-Jul-2021 | 0000000000 | |
US-20230010963-A1 | Treatment efficacy prediction systems and methods | Pending | 08-Jul-2021 | 0000000000 | 00 |
US-20200121713-A1 | Shear-thinning hydrogel, kit and method of preparation | Active | 29-Jan-2016 | 000000000 | |
US-20170312306-A1 | Shear-thinning hydrogel, kit and method of preparation | Active | 29-Jan-2016 | 000000000 | |
US-10413567-B2 | Shear-thinning hydrogel, kit and method of preparation | Active | 29-Jan-2016 | A61K31/74 |
Pear Bio Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Duleek Ranatunga | Co-Founder & Chief Executive Officer |
Pear Bio Signals
Pear Bio Investors (19)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Covalent Ventures (CV) | Venture Capital | Minority | 000 0000 | 000000 0 | |
Octopus Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Compound | Venture Capital | Minority | 000 0000 | 000000 0 | |
Crista Galli Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Fly Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |